SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
SEC Accession No. 0000921895-11-002413
Filing Date
2011-12-23
Accepted
2011-12-23 17:12:29
Documents
2
Filing Date Changed
2011-12-23

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g07422nek_12142011.htm SC 13G 196653
2 JOINT FILING AGREEMENT ex991to13g07422nek_12142011.htm EX-99.1 28489
  Complete submission text file 0000921895-11-002413.txt   226895
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Subject) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-45385 | Film No.: 111280792
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice
Assistant Director 12